publication venue for
- IgA Determines Bacterial Composition in the Gut.. 5. 2023
- The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease.. 5. 2023
- Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn's Disease and 2 Years in Ulcerative Colitis.. 4. 2022
- Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring.. 3. 2021
- Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease.. 3. 2021
- Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease.. 2. 2020